Newsletter | January 5, 2026

01.05.26 -- Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

FROM THE EDITOR

Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

 Bruce Culleton, M.D., shares lessons from his shift from academia to biotech leadership and how mentorship shaped his path. Explore insights on driving innovation in chronic kidney disease and bridging research with real-world impact.
 

INDUSTRY INSIGHTS

Busting Through Patient Recruitment Barriers

Building patient trust fuels engagement, data and technology enable targeted recruitment, and real-time patient identification with consistent support drives scalable enrollment success.

How Cloud ERP Overcomes Hidden Costs And Customization Constraints

Discover how cloud ERP systems provide businesses with the flexibility to scale and adapt quickly to market changes, as well as benefit from seamless updates without extensive customization.

Making The Lives Of Patients And Research Sites Easier

Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change — and the impact is significant.

Charlotte: A Global Hub For Health Care Innovation And MedTech

Charlotte’s Pearl is a vibrant hub driving health care innovation — advancing surgery, diagnostics, and digital health through research, education, and medtech collaboration for global impact.

Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories

Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.

Unified Patient Apps: The Future Of Trial Simplicity

A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments — reducing burden, improving engagement, and supporting better retention and data quality.

Top Approach To High Volume Enrollment In Clinical Research

Integrating technology with personalized support can ethically, efficiently, and transparently scale patient recruitment, ultimately improving trial outcomes and advancing translational research.